Valuation: Astal Laboratories Limited

Market Cap 275.92Cr 2.85Cr 2.51Cr 2.33Cr 2.14Cr 4.02Cr 4.09Cr 28Cr 11Cr 134.58Cr 11Cr 10Cr 466.91Cr P/E 2024
26.3x
P/E 2025 9.45x
Enterprise Value 287.46Cr 2.97Cr 2.61Cr 2.43Cr 2.23Cr 4.18Cr 4.26Cr 29Cr 11Cr 140.21Cr 11Cr 11Cr 486.43Cr EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
41.06%
Yield 2024 *
-
Yield 2025 -
1 day-1.40%
1 week+0.35%
Current month-10.85%
1 month+1.55%
3 months+25.59%
6 months-4.39%
Current year-8.68%
1 week 77.5
Extreme 77.5
83.89
1 month 77.5
Extreme 77.5
91.3
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 24
Extreme 24
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 15/07/2023
Compliance Officer 32 19/04/2023
Director TitleAgeSince
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-1.40%+0.35%-13.29%+192.12% 3.63Cr
+1.97%+1.43%+48.44%+156.66% 1,05700Cr
+1.42%+3.72%+53.32%+52.34% 62TCr
+1.43%+0.99%+34.83%+78.74% 45TCr
+0.93%+5.12%+32.52%+28.45% 34TCr
-0.37%+1.84%+36.11%+40.20% 30TCr
-0.69%+0.11%+15.61%+16.96% 26TCr
-0.59%-3.46%-28.76%-42.09% 22TCr
+1.49%-0.02%+20.14%+58.21% 20TCr
+0.40%-3.99%+15.23%+62.28% 16TCr
Average +0.44%+0.56%+21.41%+64.39% 36.14TCr
Weighted average by Cap. +1.06%+1.57%+35.01%+75.51%

Financials

2024 2025
Net sales 24Cr 24.43L 21.49L 19.96L 18.36L 34.43L 35.05L 2.39Cr 93.11L 12Cr 91.73L 89.74L 40Cr 64Cr 65.73L 57.81L 53.71L 49.39L 92.63L 94.29L 6.42Cr 2.5Cr 31Cr 2.47Cr 2.41Cr 107.72Cr
Net income 78.47L 81.03T 71.27T 66.2T 60.89T 1L 1L 8L 3L 38.27L 3L 3L 1.33Cr 8.93Cr 9L 8L 8L 7L 12.99L 13.22L 90.05L 35.12L 4.35Cr 34.6L 33.85L 15Cr
Net Debt -5.76Cr -6L -5L -5L -4L -8L -9L -58.16L -22.68L -2.81Cr -22.35L -21.86L -9.75Cr 12Cr 11.91L 10.48L 10L 9L 16.79L 17.09L 1.16Cr 45.4L 5.63Cr 44.73L 43.76L 20Cr
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
24/26/24 79.31 -1.40% 7,599
23/26/23 ₹80.44 +1.81% 9,889
22/26/22 ₹79.01 -2.79% 9,475
21/26/21 ₹81.28 -0.67% 6,819
20/26/20 ₹81.83 +3.54% 10,244
  1. Stock Market
  2. Stocks
  3. MACINTR Stock